GNbAC1, a Humanized Monoclonal Antibody Against the Envelope Protein of Multiple Sclerosis—Associated Endogenous Retrovirus: A First-in-Humans Randomized Clinical Study-Reference-Cited by-同舟云学术

GNbAC1, a Humanized Monoclonal Antibody Against the Envelope Protein of Multiple Sclerosis—Associated Endogenous Retrovirus: A First-in-Humans Randomized Clinical Study

Published:2012-12 Issue:12 Volume:34 Page:2268-2278
ISSN:0149-2918
Container-title:Clinical Therapeutics
language:en
Short-container-title:Clinical Therapeutics

Author:

Curtin François,Lang Alois B.,Perron Hervé,Laumonier Marion,Vidal Virginie,Porchet Hervé C.,Hartung Hans-Peter

Publisher

Elsevier BV

Subject

Pharmacology (medical),Pharmacology

Reference18 articles.

1. The immunopathology of multiple sclerosis: an overview;Lassmann;Brain Pathol,2007

2. Recent developments in multiple sclerosis therapeutics;Spain;BMC Med,2009

3. Leptomeningeal cell line from multiple sclerosis with reverse transcriptase activity and viral particles;Perron;Res Virol,1989

4. Isolation of retrovirus from patients with multiple sclerosis;Perron;Lancet,1991

5. Molecular identification of a novel retrovirus repeatedly isolated from patients with multiple sclerosis;Perron;Proc Natl Acad Sci U S A,1997

Cited by 65 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Endogenous retroviruses in multiple sclerosis: A network-based etiopathogenic model;Ageing Research Reviews;2024-08

2. Development of human endogenous retrovirus type K‐ related treatments for human diseases;Journal of Medical Virology;2024-03

3. Treatment of autoimmunity: The impact of disease-modifying therapies in multiple sclerosis and comorbid autoimmune disorders;Autoimmunity Reviews;2023-05

4. Targeting the Brain with Single-Domain Antibodies: Greater Potential Than Stated So Far?;International Journal of Molecular Sciences;2023-01-30

5. Human Endogenous Retroviruses in Diseases;Subcellular Biochemistry;2023